Rifaioglu AS, Atas H, Martin MJ, Cetin-Atalay R, Atalay V, Doğan T. Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases. Brief Bioinform. 2019;20:1878–912.
Article CAS PubMed Google Scholar
Iwata H. Application of in Silico Technologies for Drug Target Discovery and Pharmacokinetic Analysis. Chem Pharm Bull (Tokyo). 2023;71:398–405.
Article CAS PubMed Google Scholar
Nag S, Baidya A, Mandal A, Mathew AT, Das B, Devi B, Kumar R. Deep learning tools for advancing drug discovery and development. 3 Biotech. 2022;12:110.
Article PubMed PubMed Central Google Scholar
Naga D, Parrott N, Ecker GF, Olivares-Morales A. Evaluation of the success of high-throughput physiologically based pharmacokinetic (HT-PBPK) modeling predictions to inform early drug discovery. Mol Pharm. 2022;19:2203–16.
Article CAS PubMed PubMed Central Google Scholar
Jayaraj PB, Jain S. Ligand based virtual screening using SVM on GPU. Comput Biol Chem. 2019;83:107143.
Article CAS PubMed Google Scholar
Shaker B, Ahmad S, Lee J, Jung C, Na D. In silico methods and tools for drug discovery. Comput Biol Med. 2021;137:104851.
Dezső Z, Ceccarelli M. Machine learning prediction of oncology drug targets based on protein and network properties. BMC Bioinforma. 2020;21:1–12.
Pliakos K, Vens C. Drug-target interaction prediction with tree-ensemble learning and output space reconstruction. BMC Bioinforma. 2020;21:11.
Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet], British Medical Journal Publishing Group, 2021.
“WoS Query”, Accessed: Jan. 06, 2024. [Online]. Available: https://www.webofscience.com/wos/woscc/summary/60417e9f-5b12-4a50-b463-97d9caf10abc-c2f38ce2/relevance/1
Niazi SK, Mariam Z. Recent advances in machine-learning-based chemoinformatics: a comprehensive review. Int J Mol Sci. 2023;24:11488.
Article CAS PubMed PubMed Central Google Scholar
Podlewska S, Kurczab R. Mutual Support of Ligand-and Structure-Based Approaches—To What Extent We Can Optimize the Power of Predictive Model? Case Study of Opioid Receptors. Molecules. 2021;26:1607.
Article CAS PubMed PubMed Central Google Scholar
Onawole AT, Hussein IA, Saad MA, Ahmed MEM, Nimir H. Computational screening of potential inhibitors of desulfobacter postgatei for pyrite scale prevention in oil and gas wells. ACS Omega. 2021;6:10607–17.
Article CAS PubMed PubMed Central Google Scholar
Wang Z, Belecciu T, Eaves J, Reimers M, Bachmann MH, Woldring D. Phytochemical drug discovery for COVID-19 using high-resolution computational docking and machine learning assisted binder prediction. J Biomol Struct Dyn. 2023;41:6643–6663.
Article CAS PubMed Google Scholar
Wu Y, Song Z, Little JC, Zhong M, Li H, Xu Y. An integrated exposure and pharmacokinetic modeling framework for assessing population-scale risks of phthalates and their substitutes. Environ Int. 2021;156:106748.
Article CAS PubMed Google Scholar
Jiang D, Lei T, Wang Z, Shen C, Cao D, Hou T. ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning. J Cheminform. 2020;12:1–26.
Huang X, Tang F, Hua Y, Li X. In silico prediction of drug-induced ototoxicity using machine learning and deep learning methods. Chem Biol Drug Des. 2021;98:248–57.
Article CAS PubMed Google Scholar
Mamoshina P, Bueno-Orovio A, Rodriguez B. Dual transcriptomic and molecular machine learning predicts all major clinical forms of drug cardiotoxicity. Front Pharm. 2020;11:639.
Meng J, Zhang L, Wang L, Li S, Xie D, Zhang Y, Liu H. TSSF-hERG: A machine-learning-based hERG potassium channel-specific scoring function for chemical cardiotoxicity prediction. Toxicology. 2021;464:153018.
Article CAS PubMed Google Scholar
Kadioglu O, Klauck SM, Fleischer E, Shan L, Efferth T. Selection of safe artemisinin derivatives using a machine learning-based cardiotoxicity platform and in vitro and in vivo validation. Arch Toxicol. 2021;95:2485–95.
Article CAS PubMed PubMed Central Google Scholar
Nath A, Sahu GK. Exploiting ensemble learning to improve prediction of phospholipidosis inducing potential. J Theor Biol. 2019;479:37–47.
Article CAS PubMed Google Scholar
“EMA in London.” Accessed: Jan. 07, 2024. [Online]. Available: https://www.ema.europa.eu/en/about-us/history-ema/ema-london-1995-2019
“Basel.” Accessed: Jan. 07, 2024. [Online]. Available: https://baselarea.swiss/blog-post/biotech-companies-wing-their-way-to-the-basel-area/
Zdrazil, B. et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods, Nucleic Acids Res. p. gkad1004, 2023.
“ChEMBL.” Accessed: Jan. 04, 2024. [Online]. Available: https://www.ebi.ac.uk/chembl/
Zhao J, Yang J, Tian S, Zhang W. A survey of web resources and tools for the study of TCM network pharmacology. Quant Biol. 2019;7:17–29.
Patel L, Shukla T, Huang X, Ussery DW, Wang S. Machine learning methods in drug discovery. Molecules. 2020;25:5277.
Article CAS PubMed PubMed Central Google Scholar
Carracedo-Reboredo P, Liñares-Blanco J, Rodríguez-Fernández N, Cedrón F, Novoa FJ, Carballal A, et al. A review on machine learning approaches and trends in drug discovery. Comput Struct Biotechnol J. 2021;19:4538–58.
Article CAS PubMed PubMed Central Google Scholar
Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15:1916.
Article CAS PubMed PubMed Central Google Scholar
Udegbe FC, Ebulue OR, Ebulue CC, Ekesiobi CS. Machine Learning in Drug Discovery: A critical review of applications and challenges. Computer Sci IT Res J. 2024;5:892–902.
Dara S, Dhamercherla S, Jadav SS, Babu CHM, Ahsan MJ. Machine learning in drug discovery: a review. Artif Intell Rev. 2022;55:1947–99.
Zhong Z, Barkova A, Mottin, D. Knowledge-augmented graph machine learning for drug discovery: A survey from precision to interpretability, arXiv preprint arXiv:2302.08261, 2023. https://doi.org/10.48550/arXiv.2302.08261
Boswell Z, et al. In-Silico Approaches for the Screening and Discovery of Broad-Spectrum Marine Natural Product Antiviral Agents Against Coronaviruses. Infect Drug Resist. 2023;2321–38.
Vatansever S, Schlessinger A, Wacker D, Kaniskan HÜ, Jin J, Zhou MM, Zhang B. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions. Med Res Rev. 2021;41:1427–73.
Kim H, Kim E, Lee I, Bae B, Park M, Nam H. Artificial intelligence in drug discovery: a comprehensive review of data-driven and machine learning approaches. Biotechnol Bioprocess Eng. 2020;25:895–930.
Article CAS PubMed Google Scholar
Seifert MHJ, Wolf K, Vitt D. Virtual high-throughput in silico screening. Biosilico. 2003;1:143–9.
Birkholtz L-M, et al. In silico Discovery of Chemotherapeutic Agents, in Infectious Disease Informatics, Springer, 2009, pp. 279–304.
Kline A, Wang H, Li Y, Dennis S, Hutch M, Xu Z, et al. Multimodal machine learning in precision health: A scoping review. NPJ Digit Med. 2022;5:171.
Article PubMed PubMed Central Google Scholar
Lipkova J, Chen RJ, Chen B, Lu MY, Barbieri M, Shao D, et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell. 2022;40:1095–110.
留言 (0)